SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-23-004866
Filing Date
2023-02-14
Accepted
2023-02-14 16:06:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 87436
  Complete submission text file 0001493152-23-004866.txt   88910
Mailing Address 203 CRESCENT STREET BUILDING 17, SUITE #102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BUILDING 17, SUITE #102B WALTHAM MA 02453 919-949-8552
Viridian Therapeutics, Inc. (Subject) CIK: 0001811466 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93466 | Film No.: 23628878

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A